Index Entries - Covid Index

1995 Results

Title	IS Publication Date
Ivermectin as Prophylaxis Against COVID-19 Retrospective Cases Evaluation	December 2020
Ivermectin Could Have Saved Millions of Lives, Why Was It Suppressed	June 20, 2023
Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2	August 31, 2020
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes	February 29, 2024
Ivermectin for COVID-19: Real-time meta-analysis of 99 studies	November 26, 2020
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines	July / August 2021
Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial	May 13, 2021
Ivermectin prophylaxis used for COVID-19 reduces COVID-19 infection and mortality rates: A 220,517-subject, populational-level retrospective citywide observational study	January 2022
Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching	January 15, 2022
Ivermectin reduces in vivo coronavirus infection in a mouse experimental model	March 30, 2021
Ivermectin, ‘Wonder drug’ from Japan: the human use perspective	February 10, 2011
Ivermectin: A Drug Worthy of a Nobel Prize, but Inaccessible for Those Who Need It	October 25, 2015
Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19	August 3, 2021
Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen	June 12, 2020
Ivermectin: an award-winning drug with expected antiviral activity against COVID-19	October 7, 2020
Ivermectin: enigmatic multifaceted ‘wonder’ drug continues to surprise and exceed expectations	February 15, 2017
Jab Injuries Australia
Japan's H1 excess mortality highest since Covid pandemic	October 9, 2022
Japanese Professor Upends Ministry of Health: Disband Vax Committee, Investigate All Injuries	December 1, 2022
Jeffrey Sachs on COVID-19 – “I’m pretty convinced it came out of US lab biotechnology"	June 2022
Johnson & Johnson clinical trial: A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants	First posted August 10, 2020; last update May 6, 2023
Kansas AG sues Pfizer for misleading Kansans on COVID vaccine	June 17, 2024
Kids and Speech Delays	January 26, 2022
Killer Jab? 24% Say Someone They Know Died From COVID-19 Vaccine	November 2nd, 2023
Kolaviron (Kolaflavanone), apigenin, fisetin as potential Coronavirus inhibitors: In silico investigation	August 4, 2020
Kounis syndrome following COVID-19 vaccination: Clinical manifestations, mechanisms and management	June 19, 2024
Lab Leak - The True Origins of COVID-19	April 18, 2025
Laboratory testing for coronavirus disease (COVID-19) in suspected human cases	March 19, 2020
Lack of correlation between school mask mandates and paediatric COVID-19 cases in a large cohort	November 29, 2022
Large-scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection	December 31, 2021
Largest Statistically Significant Study by 6,200 Multi-Country Physicians on COVID-19 Uncovers Treatment Patterns and Puts Pandemic in Context	April 2, 2020
Lasting immunity found after recovery from COVID-19	January 26, 2021
Latest statistics on England mortality data suggest systematic mis-categorisation of vaccine status and uncertain effectiveness of Covid-19 vaccination	December 3, 2021
Legal Letter on Behalf of Physicians Regarding Covid-19 Vaccine Injuries (to heads of the DHHS, CDC, and FDA)	October 27, 2021
Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)	February 22, 2021
Lessons Learned from FEMA’s Initial Response to COVID-19	September 21, 2021
Letter from a Los Angeles Psychiatrist to his Patients	February 2022
Letter from Ron Johnson to HHS, FDA and CDC directing them to preserve all records relating to COVID-19 vaccines	November 19, 2024
Letter from Senator Ron Johnson to Lloyd J. Austin III, Secretary of the Department of Defense	February 1, 2022
Letter from US Senators to USAID regarding funding and activities of EcoHealth Alliance	September 14, 2022
Letter of inquiry from the US House Committee on Oversight and Reform to Dr. Kristian Andersen	February 3, 2022
Letter to the Chief Executive of the UK Medicines and Healthcare Products Regulatory Agency: Urgent preliminary report of Yellow Card data up to 26th May 2021	June 9, 2021
Letter to the Editor: As an Oncologist I Am Seeing People With Stable Cancer Rapidly Progress After Being Forced to Have a Booster	November 22, 2023
Letter to the Editor: Long-Term Prognosis of Patients With Myocarditis Attributed to COVID-19 mRNA Vaccination, SARS-CoV-2 Infection, or Conventional Etiologies	November 5, 2024
Letter to the Editor: Meta-analysis on facemask use in community settings to prevent respiratory infection transmission shows no effect	November 16, 2020
Letter to the Editor: Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden	February 18, 2021
Letter to the Editor: Previous COVID-19 infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccination	April 22, 2021
Letter to the Editor: Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections	November 24, 2021
Letter to the FDA: Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT), a New and Dangerous Syndrome from Certain COVID Vaccines – Do We Have Them All?	October 24, 2022
Letter to U.S. Food and Drug Administration, Vaccines and Related Biological Products Advisory Committee in response to “Request for Comments related to consideration of vaccines against SARS-CoV-2”	December 8, 2020

Page 21 of 40